DNA damage—how and why we age?

M Yousefzadeh, C Henpita, R Vyas, C Soto-Palma… - Elife, 2021 - elifesciences.org
Aging is a complex process that results in loss of the ability to reattain homeostasis following
stress, leading, thereby, to increased risk of morbidity and mortality. Many factors contribute …

Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors

N Bansal, MJ Adams, S Ganatra, SD Colan… - Cardio-Oncology, 2019 - Springer
Cancer diagnostics and therapies have improved steadily over the last few decades,
markedly increasing life expectancy for patients at all ages. However, conventional and …

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic …

AR Lyon, T Lopez-Fernandez, LS Couch… - European Heart …, 2022 - academic.oup.com
ESC Guidelines e341 (1) the specific situation of the patient. In this respect, it is specified
that, unless otherwise provided for by national regulations, offlabel use of medication should …

Cardiovascular toxicity related to cancer treatment: a pragmatic approach to the American and European cardio‐oncology guidelines

J Alexandre, J Cautela, S Ederhy… - Journal of the …, 2020 - Am Heart Assoc
The considerable progress made in the field of cancer treatment has led to a dramatic
improvement in the prognosis of patients with cancer. However, toxicities resulting from …

Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic …

H Strongman, S Gadd, A Matthews, KE Mansfield… - The Lancet, 2019 - thelancet.com
Background The past few decades have seen substantial improvements in cancer survival,
but concerns exist about long-term cardiovascular disease risk in survivors. Evidence is …

Assessment of prognostic value of left ventricular global longitudinal strain for early prediction of chemotherapy-induced cardiotoxicity: a systematic review and meta …

EK Oikonomou, DG Kokkinidis, PN Kampaktsis… - JAMA …, 2019 - jamanetwork.com
Importance Echocardiographic left ventricular global longitudinal strain (GLS) detects early
subclinical ventricular dysfunction and can be used in patients receiving potentially …

Derivation of anthracycline and anthraquinone equivalence ratios to doxorubicin for late-onset cardiotoxicity

EAM Feijen, WM Leisenring, KL Stratton… - JAMA …, 2019 - jamanetwork.com
Importance Anthracyclines are part of many effective pediatric cancer treatment protocols.
Most pediatric oncology treatment groups assume that the hematologic toxicity of …

Cardiac Disease in Childhood Cancer Survivors: Risk Prediction, Prevention, and Surveillance: JACC CardioOncology State-of-the-Art Review

JM Leerink, EC de Baat, EAM Feijen, L Bellersen… - Cardio Oncology, 2020 - jacc.org
Cardiac diseases in the growing population of childhood cancer survivors are of major
concern. Cardiotoxicity as a consequence of anthracyclines and chest radiotherapy …

Late health outcomes after dexrazoxane treatment: a report from the Children's Oncology Group

EJ Chow, R Aplenc, LM Vrooman, DR Doody… - Cancer, 2022 - Wiley Online Library
Background The objective of this study was to examine long‐term outcomes among children
newly diagnosed with cancer who were treated in dexrazoxane‐containing clinical trials …

Dexrazoxane and long-term heart function in survivors of childhood cancer

EJ Chow, S Aggarwal, DR Doody, R Aplenc… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE For survivors of childhood cancer treated with doxorubicin, dexrazoxane is
cardioprotective for at least 5 years. However, longer-term data are lacking. METHODS …